Browse our comprehensive collection of market intelligence reports.
Cachexia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Cachexia Pipeline Analysis report covers 21 drugs currently in different phases of development. Cachexia or muscle wasting is a condition characterised by extreme weight loss and muscle wasting including body fat. It generally affects the people with serious
Autoimmune Hepatitis Pipeline Analysis report covers drugs of 7 companies currently in different phases of development. Autoimmune hepatitis is a long-lasting disease in which the body’s immune system fights against the normal liver cells instead of fighting against bacteria, viruses or other foreign substances. This gives rise to the liver inflammation leading to liver damage and failure. If diagnosed early, autoimmune hepatitis can be treated vi
Alport Syndrome Pipeline Analysis report covers more than 5 drugs currently in different phases of development. Alport Syndrome is an inherited disorder involving the glomerular basement membrane of the kidney. The disease is characterized by loss of kidney function, hearing loss, and ophthalmic disorders. Symptoms of the disease are hematuria, nep
Alagille Syndrome Pipeline Analysis report covers therapies which include companies and research organizations or institutes, in total 4 in number currently in different phases of development. Alagille syndrome (ALGS) is a genetic disorder which occurs due to the mutations caused in either of the JAG1 or NOTCH2 gene. The genes instruct in making pr
Adrenoleukodystrophy is a rare genetic disorder characterised by loss or damage of myelin sheath surrounding and insulating the nerve cells. The damage of the myelin sheath further leads to the progressive loss of the fuctioning of the adrenal glands. Symptoms of adrenoleukodystrophy are muscle spasms and pain, impaired vision, trouble balancing the body, deterioration of motor control, Adrenal insufficiency and lethargy and clumsiness. Diagnosi
Hairy cell leukemia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Hairy cell leukemia Pipeline Analysis report covers drugs of 8 companies currently in different phases of development. Hairy cell leukemia is a rare type of white blood cells cancer where the bone marrow makes too many lymphocytes (B cells). B cell
Meningioma Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Meningioma Pipeline Analysis report covers 13 drugs currently in different phases of development. Meningioma is the tumor that develops in the layer called meninges which protect the brain and spinal cord. These are the most common form of tumors, slow grow
Transthyretin (TTR) Related Amyeloidosis (ATTR) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Transthyretin (TTR) Related Amyeloidosis Pipeline Analysis report covers 11 drugs currently in different phases of development. Transthyretin (TTR) Related Amyeloidosis or ATTR is a rare, progressive condition characteri
Familial Partial Lipodystrophy (FPLD) Pipeline Analysis report covers 3 drugs currently in different phases of development. FPLD is a rare, genetic condition characterized by the abnormal fat distribution in the body. Adipose tissue surrounding the internal organs and just beneath the skin is responsible for storing the fat. In people with FPLD adi
Homozygous Familial Hypercholesterolemia (HoFH) Pipeline Analysis report covers 7 drugs currently in different phases of development. HoFH is an inherited rare disorder characterised by difficult lipoprotein metabolism and extremely high level of circulating low density lipoprotein cholesterol (ranging between 500 and 1200 mg/dl.). These high level of cholesterol accumulates in the arteries leading to cardiovascular disease much faster than in t
Retinoschisis Pipeline Analysis report covers 2 drugs currently in different phases of development. Retinoschisis is an ophthalmic condition where part of retina is split into two layers. The split part of retina is characterised by suboptimal vision. The retinoschisis may be classified into two types: Genetic Juvenile X-linked Retinoschisis and acquired Degenerative retinoschisis. Symptoms of retinoschisis are decreased central and peripheral v
Malignant Rhabdoid Tumour (MRT) Pipeline Analysis report covers drugs of 4 companies currently in different phases of development. Malignant rhabdoid tumour (MRT) is a rare childhood disorder and its occurrence is commonly seen in the kidneys. It can also occur in the brain or soft tissues and is known as the atypical teratoid rhabdoid tumour (ATRT). Cells of MRT can spread to the other parts of the body as well and it usually occurs in infants